Sartorius Stedim Biotech S.A. (0RG8)
LSE
Closed
Oct 8, 2026
Day's Range
207.5052 wk Range
150.00Overview - 0RG8 - Sartorius Stedim Biotech S.A.
Key Statistics
Valuation
Enterprise Value
20.52B
P/E (Trailing)
‪31.08‬
PEG Ratio
‪3.41‬
Price / Sales (TTM)
‪8.28‬
Price / Book
‪7.58‬
EV / EBITDA
‪23.35‬
Profitability
Gross Margin
‪46.85%‬
Profit Margin
‪15.56%‬
Operating Margin
‪23.22%‬
Return on Assets
‪6.57%‬
Return on Equity
‪18.65%‬
Ownership
Shares Outstanding
97.29M
Float
24.21M
Held by Insiders
‪73.59%‬
Held by Institutions
‪13.94%‬
Price stats
Beta
‪0.47‬
50-Day Avg
‪185.58‬
200-Day Avg
‪181.46‬
Dividends
Payout Ratio
‪20.87%‬
Frequency
Annual
Market Cap - 0RG8 - Sartorius Stedim Biotech S.A.
Peers - 0RG8 - Sartorius Stedim Biotech S.A.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on LSE.
- 0RG8LSESartorius Stedim Biotech S.A.24.51BMarket Cap+20.26%52-week change31.09P/E (Trailing)‪15.56%‬Profit Margin
- CTECLSEConvaTec Group Plc415.20BMarket Cap-10.06%52-week change43.32P/E (Trailing)‪4.97%‬Profit Margin
- MRCLSEMercantile Investment Trust184.28BMarket Cap+14.01%52-week change9.99P/E (Trailing)—Profit Margin
- AGTLSEAVI Global Trust PLC104.81BMarket Cap+1.32%52-week change22.00P/E (Trailing)‪79.64%‬Profit Margin
- 0QBOLSEColoplast A/S96.67BMarket Cap-32.13%52-week change18.58P/E (Trailing)‪19.66%‬Profit Margin
- 0OMKLSEEssilorLuxottica65.28BMarket Cap-92.27%52-week change27.50P/E (Trailing)‪9.22%‬Profit Margin
- ATRLSESchroder Asian Total Return Investment Company plc64.98BMarket Cap+28.61%52-week change10.13P/E (Trailing)—Profit Margin
Profile Summary - 0RG8 - Sartorius Stedim Biotech S.A.
About
Sartorius Stedim Biotech S.A. is a leading international provider of innovative equipment and services for the biopharmaceutical industry and life sciences research. The company specializes in single-use technologies, laboratory instruments, consumables, and bioprocess solutions that support the development, quality…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
